Immunovant (IMVT) Amortizatization of Intangibles (2020 - 2026)
Immunovant (IMVT) reported Amortizatization of Intangibles of $26000.0 for Q1 2026, up 18.18% on a YoY basis from $22000.0 in Q1 2025, and up 4.0% quarter-over-quarter from $25000.0 in Q4 2025.
Immunovant (IMVT) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Immunovant has reported Amortizatization of Intangibles for 7 years, with the latest figure at $26000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 18.18% year-over-year to $26000.0; the trailing twelve-month figure through Mar 2026 stood at $99000.0 (down 25.56% YoY), and the FY2026 full-year result was $99000.0, down 25.56% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $26000.0, up from $25000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $295000.0 in Q4 2023, with the low at $22000.0 in Q3 2024.
- Historically, Amortizatization of Intangibles has averaged $162823.5 across 5 years, with a median of $252000.0 in 2024.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles climbed 25.57% — and 2024, when it sank 92.49%.
- Immunovant's Amortizatization of Intangibles stood at $284000.0 in 2022, then gained by 3.87% to $295000.0 in 2023, then tumbled by 92.2% to $23000.0 in 2024, then grew by 8.7% to $25000.0 in 2025, then advanced by 4.0% to $26000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $26000.0 (Q1 2026), $25000.0 (Q4 2025), and $24000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Immunovant | 5.71 Bn | 5.71 Bn | - | 26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | 252,000.00 |
| Mar 31, 2024 | 252,000.00 |
| Dec 31, 2023 | 295,000.00 |
| Dec 31, 2023 | 295,000.00 |